Funding for the innovative center should boost the technological economy, facilitate scientific collaboration and foster entrepreneurship in Puerto Rico. #NewsismyBusiness
CytoImmune Therapeutics, Inc. and Biosimilar Solutions, LLC will establish operations in Puerto Rico to develop their biotechnology products. Both initiatives represent a combined investment of some $228 million and the creation of 400 jobs, economic development organization Invest Puerto Rico announced. While CytoImmune Therapeutics will engage in developing cancer immunotherapy solutions, Biosimilar Sciences will work […]
INDUNIV, an organization that for 38 years has been the voice of the bioscience industry in Puerto Rico, will represent the island at the BIO International Convention,” in Boston from June 4-7.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
